Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 gag targeting to the plasma membrane

被引:431
作者
Ono, A [1 ]
Ablan, SD
Lockett, SJ
Nagashima, K
Freed, EO
机构
[1] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21702 USA
[2] NCI, Image Anal Lab, Res Technol Program, SAIC Frederick, Frederick, MD 21702 USA
关键词
D O I
10.1073/pnas.0405596101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A critical early event in the HIV type 1 (HIV-1) particle assembly pathway is the targeting of the Gag protein to the site of virus assembly. In many cell types, assembly takes place predominantly at the plasma membrane. Cellular factors that regulate Gag targeting remain undefined. The phosphoinositide phosphaticlylinositol (4,5) bisphosphate [PI(4,5)P-2] controls the plasma membrane localization of a number of cellular proteins. To explore the possibility that this lipid maybe involved in Gag targeting and virus particle production, we overexpressed phosphoinositicle 5-phos-phatase IV, an enzyme that depletes cellular PI(4,5)P-2, or overexpressed a constitutively active form of Arf6 (Arf6/Q67L), which induces the formation of PI(4,5)P-2-enriched endosomal structures. Both approaches severely reduced virus production. Upon 5-phos-phatase IV overexpression, Gag was no longer localized on the plasma membrane but instead was retargeted to late endosomes. Strikingly, in cells expressing Arf6/Q67L, Gag was redirected to the PI(4,5)P-2-enriched vesicles and HIV-1 virions budded into these vesicles. These results demonstrate that PI(4,5)P-2 plays a key role in Gag targeting to the plasma membrane and thus serves as a cellular determinant of HIV-1 particle production.
引用
收藏
页码:14889 / 14894
页数:6
相关论文
共 57 条
[31]   EFFICIENT PARTICLE FORMATION CAN OCCUR IF THE MATRIX DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG IS SUBSTITUTED BY A MYRISTYLATION SIGNAL [J].
LEE, PP ;
LINIAL, ML .
JOURNAL OF VIROLOGY, 1994, 68 (10) :6644-6654
[32]   Phosphoinositide recognition domains [J].
Lemmon, MA .
TRAFFIC, 2003, 4 (04) :201-213
[33]   Human immunodeficiency virus type 1 Gag contains a dileucine-like motif that regulates association with multivesicular bodies [J].
Lindwasser, OW ;
Resh, MD .
JOURNAL OF VIROLOGY, 2004, 78 (11) :6013-6023
[34]   Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity [J].
Martin-Kleiner, I ;
Bidlack, JM .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (01) :13-20
[35]   Convergence of non-clathrin-and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides [J].
Naslavsky, N ;
Weigert, R ;
Donaldson, JG .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (02) :417-431
[36]   Evidence that HIV budding in primary macrophages occurs through the exosome release pathway [J].
Nguyen, DG ;
Booth, A ;
Gould, SJ ;
Hildreth, JEK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52347-52354
[37]   HIV-1 egress is gated through late endosomal membranes [J].
Nydegger, S ;
Foti, M ;
Derdowski, A ;
Spearman, P ;
Thali, M .
TRAFFIC, 2003, 4 (12) :902-910
[38]   Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body [J].
Ono, A ;
Freed, EO .
JOURNAL OF VIROLOGY, 2004, 78 (03) :1552-1563
[39]   Role of the gag matrix domain in targeting human immunodeficiency virus type 1 assembly [J].
Ono, A ;
Orenstein, JM ;
Freed, EO .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2855-2866
[40]   Infectious HIV-1 assembles in late endosomes in primary macrophages [J].
Pelchen-Matthews, A ;
Kramer, B ;
Marsh, M .
JOURNAL OF CELL BIOLOGY, 2003, 162 (03) :443-455